…German colleagues and partners, further develop what we call the ÖKS-Hamburg region into a world-leading Life Science centre”, says Kajsa M. Paulsson, researcher at Lund University and HALOS project manager….
…MAX IV Laboratory “At this stage, we are analysing the surface layer to get information about the chemical composition and electronic state of the passive films: the thickness, composition, and…
…auto-processing results in EXI Documentation: How to prepare sample shipments with EXI at MAX IV Video tutorial on declaring and shipping samples: https://lu.app.box.com/s/e517lz66f1yiop35ev0p998l4v17xsze Inspecting Processing Results Using EXI Tutorial 2. Computer…
How can tomorrow’s solar cells become even more energy efficient? This is what pioneering company Epishine is currently investigating at the MAX IV beamline HIPPIE. Swedish cleantech company Epishine’s patented manufacturing process…
…by the PRISMAS management team based on expertise and experience. The list of selected eligible candidates is handed to the Local Evaluation Committee at the respective university. The committee invites the candidates to a first online interview. As the main Principal Investigator of the…
…is well suited to the latter, often resulting in data quality comparable or better that can be obtained by manual control of the experiment. How does automated data collection work?…
Modern-time manufacturing creates new challenges to tackle. So does additive manufacturing which is foreseen as the future of sustainable and cost-efficient production. Additive manufacturing (AM), known by many as 3D printing,…
…Manager, ForMAX beamline, MAX IV. https://www.youtube.com/watch?v=K6YyBSmyt74 Read the full press release here. Read more about ForMAX and watch the ForMAX introduction video here. Visit Treesearch or Knut and Alice Wallenberg…
…EST@maxiv.lu.se if you have queries or require support. Complete Safety Test The safety training is mandatory for gaining access to the MAX IV building. Download the reading materials for your…
Ganciclovir, a regular medicine used to treat human cytomegalovirus (HCMV) infections, was found less efficient when reacting to human’s NUDT15 enzyme — based on a recent BioMAX study. This finding…